Clinical pharmacy is defined as that area of pharmacy concerned with the signs and practice of rational medical use\[[@ref1]\]. Clinical pharmacy services are those provided by pharmacists in an attempt to promote rational drug therapy that is safe and appropriate, one of the services provided by them is pharmacovigilance\[[@ref2]\]. Presently pharmacovigilance has emerged as a part of clinical pharmacy by ensuring the best pharmaceutical care. Adverse drug reactions (ADRs) are considered to be among the leading causes of morbidity and mortality\[[@ref3]\].

According to WHO, an adverse drug reaction was originally defined in 1972 as a response to a drug that is noxious and unintended and occur at doses normally used in humans for the prophylaxis, diagnosis, or therapy of disease, or for modification of any physiological function\[[@ref4]\]. ADR reporting can alert the health care providers against the chances of occurrence of unexpected risks associated with the drugs. In India, pharmacovigilance program is in evolving stage and hence, pharmacists' involvement in such activities has been low\[[@ref5]\].

The World Health Organization\[[@ref6]\], The United States Food and Drug Administration\[[@ref7]\] (USFDA) and the European Medicines Agency\[[@ref8]\] (EMA) have recognized the need to evaluate the beneficial and harmful effects of drugs and to continually improve their use in order to provide appropriate, safe and effective drug therapies.

The purpose of this study was reporting, assessing, monitoring and observing the outcome of management of ADRs. The main objective was to create awareness among the health care professionals and patients on adverse drug reaction and its reporting. The implementation of ADR monitoring based on spontaneous reporting will be useful for the detection and evaluation of ADRs associated with increase in morbidity and duration of hospitalization.

A prospective study was conducted for a period of 12 months from July 2012 to June 2013 in Government Head Quarters Hospital (GHQH), Ooty, India. It is a 420-bedded hospital providing secondary healthcare to people of The Nilgiris district. Institutional ethical committee approved the study (JSSCP/DPP/IRB/01/2012-13 Date 21.10.2012).

Patients admitted in medical ward, surgical ward and pediatric ward were included. Patient with intentional or accidental poisoning, medication errors and patients with drug abuse were not included. Patient case sheets, patient medical records were used as main sources of data collection. Adverse drug reaction documentation form, Wills and Brown classification, Causality assessment scale (Naranjo\'s scale)\[[@ref9]\], Modified Hartwig and Siegel severity scale\[[@ref10]\], Schumock and Thornton preventability scale\[[@ref11]\], ADR alert card and thank you note were the various tools utilized for the conduct of study.

The clinical pharmacist who was posted in a particular ward, used to take part in the ward rounds along with the health care professionals and actively monitor for any ADRs. Patients who developed ADR were interviewed throughout their hospital stay, from the day ADR was reported. The case details were documented in ADR documentation form. ADR alert card was given to the patients who exhibited hypersensitivity type of reactions or near fatal reactions with any component of the drug. Thank you cards were issued to the healthcare professionals who reported ADR, so as to encourage further reporting. ADRs were analyzed for incidence, type of ADRs, drug classes, and individual drug. ADRs were also assessed for causality, severity and preventability using different scales.

A total number of 6,729 patients visited the particular wards during the study period. Among these, 1.29% (n=45) patients either visited the hospital with already developed ADRs or developed ADR during their stay in the hospital. This showed a similar pattern of results as reported by Arulmani *et al*.\[[@ref12]\] ([fig. 1](#F1){ref-type="fig"}).
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Out of total ADRs reported, 68.88% (n=31) involved adults, 26.66% (n=12) involved geriatric patients and 4.44% (n=2) involved pediatric patients which was similar to the results reported by Jose and Rao\[[@ref13]\].

It was observed that 84.44% (n=38) of ADRs in medical ward were reported followed by 11.11% (n=5) in surgical ward and 4.44% (n=2) in pediatric ward. This may be due to more number of patients who turned out with comorbid and chronic disease conditions. Majority of the ADRs through spontaneous reporting were due to antibiotics 31.91% (n=15) followed by H~2~ blockers 14.89% (n=7) which was similar to the study report of Chan *et al*.\[[@ref14]\] The individual drugs that produced ADRs involved ranitidine 14.89% (n=7) and ciprofloxacin 14.89% (n=7) which produced highest number of reactions such as rashes and itching ([Table 1](#T1){ref-type="table"}).
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According to the Wills and Brown classification, the majority of the ADRs 51.06% (n=24) were of Type H followed by 40.42% (n=19) of Type A reactions. The results were very much similar to Arulmani *et al*.\[[@ref12]\]. This indicated that most of the ADRs were predictable and not potentially preventable. According to the Naranjo\'s algorithm, majority of the ADRs probable were 89.36% (n=42) followed by possible 6.38% (n=3) and definite 4.25% (n=2) and the results showed similarity with a study conducted by Patel *et al*.\[[@ref15]\]. Majority of the ADRs were mild 82.97% (n=39) in severity, that is, total of 6 ADRs came under level 1 and 33 ADRs under level 2. Under moderate severity number of cases were 14.89% (n=7) and severe ADRs it was 1. On evaluation of preventability of the ADRs it was evident that most of them were not preventable 76.59% (n=36) which was similar to the results of Jose and Rao\[[@ref13]\] ([Table 2](#T2){ref-type="table"}).
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ADR reporting and monitoring program targets to identify and quantify the risks associated with the drug use and thus promoting rational use of drugs. Involvement of a pharmacist in patient care can help in prevention and early detection of ADRs. Hence the study has established the vital role of clinical pharmacist in the ADR monitoring programs.
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